Search Search Sort by Relevance Date Title Category All Categories About PSM (9) Briefings (16) Editorials (17) Interchange (33) Interchange 2011 (16) Interchange 2012 (18) Interchange 2013 (5) Interchange 2014 (12) Marv D. Shepherd, PhD (43) Press Releases (125) PSM News (20) PSM Publications (54) Article Topic (262) Alert (174) Diversion/Theft (29) Fentanyl (340) Importation (348) Legislation (64) Patient Harm (124) Policy/Enforcement News (429) World News (1,408) Consumers (114) FOIA (2) For PSM Staff (6) GLP-1 Lawsuits Library (25) Health Professions (37) Images (163) Incident Encyclopedia (92) 2005 Incidents (2) 2006 Incidents (1) 2007 Incidents (1) 2009 Incidents (6) 2010 Incidents (5) 2011 Incidents (11) 2012 Incidents (12) 2013 Incidents (22) 2014 Incidents (8) 2015 Incidents (11) 2016 Incidents (8) 2017 Incidents (4) News (2,181) Prosecution Documents Library (67) 18 USC § 1341 Mail Fraud (3) 18 USC § 1343 Wire Fraud (5) 18 USC § 1347 Health Care Fraud (3) 18 USC § 1349 Fraud attempt and conspiracy (16) 18 USC § 1956 Money Laundering (20) 18 USC § 2 Aiding and Abetting (16) 18 USC § 2320 Trafficking in counterfeit goods (2) 18 USC § 3 Accessory after the Fact (4) 18 USC § 371 Conspiracy (22) 18 USC § 542 Entry of Goods with False Statement (4) 18 USC § 545 Smuggling (7) 18 USC § 670 Theft of medical products (4) 18 USC § 922(g) and/or § 924(c) Firearm Charges (2) 18 USC § 982 Criminal Forfeiture (20) 18 USC §1001 False statements or entries generally (3) 18 USC §1962 Racketeering (2) 21 §§ 331 and 333 Unapproved drugs (31) 21 U.S. Code § 853 – Criminal forfeitures (5) 21 U.S. Code § 960 – Prohibited acts A (1) 21 U.S.C. § 843 Use of US mail for drug trafficking (2) 21 U.S.C. § 952 Importation of controlled substances (1) 21 USC § 353(e) Licensing / reporting requirements for wholesale distributors (7) 21 USC § 963 Attempt and conspiracy (1) 21 USC §§ 841 Federal Controlled Substances Act violations (16) 21 USC §§ 846 Federal Controlled Substances Act – conspiracy (17) 21 USC §848 Engaging in Continuing Criminal Enterprise (2) 21 USC 856 Maintain a drug premises (1) 28 USC §2461(c) Forfeiture (1) 42 USC § 1320a Anti-Kickback Statute (1) Pub. L. 100–293, §1(a) Prescription Drug Marketing Act violations (2) Research: All Articles (151) By Our Experts (53) Consumer/Provider Topics (44) Featured (10) Global Supply/Parallel Trade (55) Law Enforcement (9) Online Issues (32) Peer Reviewed (5) Policy and Law (33) Reporting and Data (23) Technology and Detection (32) State Resources (103) Post Type PostsPagesMedia Reset Comment_from_Life_Sciences_Pennsylvania April 7, 2020 Posted in Letters Read More Comment_from_National_Organization_for_Rare_Disorders_NORD April 7, 2020 Posted in Letters Read More Comment_from_Michigan_Pharmacists_Association April 7, 2020 Posted in Letters Read More Comment_from_National_Community_Pharmacists_Association April 7, 2020 Posted in Letters Read More Comment_from_Healthcare_Distribution_Alliance_HDA April 7, 2020 Posted in Letters Read More Comment_from_National_Sheriffs_Association April 7, 2020 Posted in Letters Read More Comment_from_HealthCare_Institute_of_New_Jersey April 7, 2020 Posted in Letters Read More Comment_from_Pharmaceutical_Security_Institute April 7, 2020 Posted in Letters Read More Comment_from_International_AntiCounterfeiting_Coalition_IACC April 7, 2020 Posted in Letters Read More Comment_from_North_Carolina_Association_of_Pharmacists April 7, 2020 Posted in Letters Read More « Previous 1 … 301 302 303 304 305 … 959 Next »
Comment_from_Life_Sciences_Pennsylvania